Official Publications argenx SE

Equities

Market Closed - Euronext Bruxelles Other stock markets 11:35:13 2024-04-29 EDT			5-day change	1st Jan Change
348.5 ^EUR	-0.23%		+3.38%	+1.46%

04-17	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT
04-16	Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy	CI

Mixed general shareholder meeting	03-25	CO
SEC Filing 20 F	03-20	CO
Annual ESG Report	03-20	CO
Annual Report	03-20	CO
SEC Filing 13G	02-28	CO
SEC Filing 6K-4	02-28	CO
Slide show results	02-28	CO
Annual results	02-28	CO
Threshold crossings	01-31	CO
Threshold crossings	01-30	CO
Threshold crossings	01-25	CO
Admission of new securities	12-30	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	12-18	CO
Threshold crossings	10-31	CO
Slide show Q3	23-10-30	CO
3rd quarter results	23-10-30	CO
SEC Filing 6K-3	23-10-30	CO
Threshold crossings	23-10-19	CO
Admission of new securities	23-09-29	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-09-19	CO
Threshold crossings	23-09-18	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-09-14	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-09-11	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-09-07	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	23-08-30	CO